Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Urgent cash needs can be stressful, but there are ways to access cash quickly. Discover effective strategies to secure funds when you need them.
21,933 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
A private equity round closes March 19 for an IP rights company that reserved a Nasdaq ticker, signaling rising inves...
Markets fall as uncertainty climbs and CEOs adopt a wartime mindset. The shift, described as every wartime now—regard...
Major acts are trimming or canceling large legs of US tours as fans face higher prices and travel costs. Industry wat...
A debt-stricken investor, once facing foreclosure at 30, built an eight-figure annual revenue business by 40 through ...
A sweeping shift in government-backed tech funding is changing how investors value IBM and Intel. Taxpayers, once dis...
Schwab’s US Large-Cap ETF (SCHX) remains a cost-efficient way to diversify across the core U.S. market. As volatility...
As the fourth quarter wrapped up, foreclosure auctions surged last, signaling rising distress in several markets. Thi...
On Oct. 14, smart retirees take one afternoon to protect cash flow and simplify their finances. This guide lays out a...
Tariff rules matter to everyday prices and jobs. This article explains why failing renew USMCA would raise uncertaint...
Public chatter suggests a behind-the-camera path for a young star. This article breaks down the personal-finance impl...
DeepMind’s 2010 seed and Google’s 2014 buyout sparked debate about exit timing in AI. This report weighs whether the ...